CAR-T therapy is an innovative treatment based on adoptive cell transfer technology. In this approach, immune cells are genetically modified to enhance their ability to target and destroy cancer cells.
Although relatively new, CAR-T therapy offers significant promise for patients with blood cancers, which often have high mortality rates. It is also generally more effective and less painful compared to traditional therapies.
